Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb

Clinical trial NCT00500786 · COMPLETED

Trial details

NCT number: NCT00500786
Sponsor: Cytos Biotechnology AG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2004-11-01
Primary completion: 2006-09-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.